Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome P450 family 51 subfamily A member 1 pseudogene 3 (CYP51A1P3) is a human pseudogene: a nonfunctional DNA sequence similar to the active CYP51A1 gene, which encodes sterol 14-demethylase, a key enzyme in the biosynthesis of sterols. CYP51A1P3 is annotated in genomic databases as lacking protein-coding ability and has no known biological function or role in drug targeting. Pseudogenes, while typically noncoding and nonfunctional, can occasionally regulate their functional counterparts at the RNA level, for example acting as miRNA decoys or through generation of siRNAs, but there is no established evidence for such activity for CYP51A1P3. It is not considered a clinical or pharmacological target and has no known impact on human disease or therapy.
None (no drugs act via this molecule)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome P450 family 51 subfamily A member 1 pseudogene 3 (CYP51A1P3).